Molecular Partners AG (MLLCF) Stock Statistics & Valuation Metrics

Molecular Partners AG has a market cap or net worth of $160.12M. The enterprise value is $60.27M.

Molecular Partners AG has 40.37M shares outstanding. The number of shares has decreased by -2.65% in one year.

Molecular Partners AG’s return on equity (ROE) is -0.38 and return on invested capital (ROIC) is -41.10%.

The current PE Ratio of Molecular Partners AG is -2.56. Molecular Partners AG’s PEG ratio is 0.16.

In the last 12 months, Molecular Partners AG had revenue of $4.97M and earned -$54.04M in profits. Earnings per share was -$1.61.

In the last 12 months, operating cash flow was -$56.79M and capital expenditures -$723.00K, giving a free cash flow of -$57.51M billion.

Molecular Partners AG pays an annual dividend of , resulting in a dividend yield of

Molecular Partners AG upcoming earnings date is Aug 25, 2025, TBA.

Molecular Partners AG as a current ratio of 14.31, with Debt / Equity ratio of 0.02

In the past 12 months, Molecular Partners AG has paid $563.72K in taxes.

Molecular Partners AG EV to EBITDA ratio is -1.49, with an EV/FCF ratio of -1.28.

Molecular Partners AG has $149.44M in cash and marketable securities with $2.44M in debt, giving a net cash position of -$147.00M billion.

Gross margin is 100.00%, with operating margin of -1231.73%, and net profit margin of -1087.38%.

The average price target for Molecular Partners AG is $11.62, which is 11.43% higher than the current price. The consensus rating is Moderate Buy